OTC Watch

All stocks / BFNH

BIOFORCE NANOSCIENCES HOLDINGS, INC. BFNH

Bioforce Nanosciences Holdings (BFNH): a late 10-Q notice in May 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Estimated floatLate filing Pink LimitedVirginia, USA
Live quote on OTC Markets

Market listing

Full name
BIOFORCE NANOSCIENCES HOLDINGS INC
Market tier
OTC Pink Limited
Trading status
Active
Last trade
Nov 16
Website
www.bioforcenano.com
Source: Stockwatch, 2026-11-17

News headlines

Sky Quarry Signs Non-Binding Letter of Intent to Introduce BioForce Nanosciences to Potential Financing Sources
2026-11-11 07:45 · News Release
BioForce Nanosciences Holdings, Inc. Expands Beyond Nevada with Texas Leasehold Portfolio and Advances Herrin-1 Feasibility Evaluation
2026-10-22 12:30 · News Release
BioForce Nanosciences Holdings, Inc. Announces Major Independently Verified Potential U.S. Oil Discovery
2026-09-29 13:00 · News Release
Bioforce Nanosciences Holdings, Inc. Announces Strategic Oil and Gas Leases in Nevada
2026-07-15 09:15 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Net loss
($1,291,951)
What it means

It spends more than it earns

Under strain

The company lost $1.3 million in the year. It reported no sales.

The report says
Cash and cash equivalents
$786
Net cash used in operating activities
($65,150)
What it means

The cash could run out soon

Under strain

It had $786 in the bank and used about $5,429 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.

The report says
Total assets
$786
Total liabilities
$619,329
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $786. Its debts and unpaid bills add up to $619,329. That is about $787.95 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Estimated float2026-11-06

Estimated float about 36,831,467 shares as of 2026-11-06: 38,065,914 outstanding minus 1,234,447 held by 2 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Late filing2026-05-13

Filed NT 10-Q on 2026-05-13: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-03-31

Filed NT 10-K on 2026-03-31: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Shares outstanding

Source: SEC filings
2025-12-31
33.5M
2026-03-31
33.5M
2026-04-14
33.5M
2026-05-18
33.5M
2026-06-30
33.5M
2026-08-10
33.5M
2026-09-30
38.1M
2026-11-06
38.1M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-09 10-QQTR. REPORT - SEPT. 30, 2026
2026-10-07 8-KCURRENT REPORT
2026-09-04 3PRIMARY DOCUMENT
2026-09-04 8-KCURRENT REPORT
2026-09-04 SCHEDULE 13D
2026-09-03 3PRIMARY DOCUMENT
2026-09-02 4PRIMARY DOCUMENT
2026-09-02 4PRIMARY DOCUMENT
2026-08-18 8-KCURRENT REPORT
2026-08-14 8-KCURRENT REPORT
2026-08-10 10-QQTR. REPORT - JUNE 30, 2026
2026-07-07 8-KCURRENT REPORT

Common questions about BFNH

Does BFNH file reports with the SEC?

Yes. Bioforce Nanosciences Holdings files with the SEC under company number 0001310488. The most recent filing we hold is a 10-Q dated 2026-11-09.

Source record

How many BFNH shares are outstanding?

38,065,914 shares as of 2026-11-06, as reported to the SEC.

Source record

Has BFNH filed reports late?

Yes. In the last 12 months it filed 2 late-filing notices, most recently a NT 10-Q on 2026-05-13. A notice means a report was not ready on time; check whether the report followed.

Source record

Who runs Bioforce Nanosciences Holdings?

Officers named in its insider filings: Richard Kaiser Kaiser (CEO & CFO).

Source record

Is Bioforce Nanosciences Holdings making money?

The company lost $1.3 million in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record